231 related articles for article (PubMed ID: 28359847)
21. The pathogenesis of soluble PrP fragments containing Aβ binding sites.
Li B
Virus Res; 2016 Jan; 211():194-8. PubMed ID: 26528810
[TBL] [Abstract][Full Text] [Related]
22. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
23. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
Castello MA; Soriano S
Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
[TBL] [Abstract][Full Text] [Related]
24. Do We Need Anti-Prion Compounds to Treat Alzheimer's Disease?
Willbold D; Kutzsche J
Molecules; 2019 Jun; 24(12):. PubMed ID: 31208037
[TBL] [Abstract][Full Text] [Related]
25. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
Watanabe H
Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
[TBL] [Abstract][Full Text] [Related]
26. Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases.
Walker LC
Annu Rev Genet; 2016 Nov; 50():329-346. PubMed ID: 27893962
[TBL] [Abstract][Full Text] [Related]
27. The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease.
Walker LC; Schelle J; Jucker M
Cold Spring Harb Perspect Med; 2016 Jul; 6(7):. PubMed ID: 27270558
[TBL] [Abstract][Full Text] [Related]
28. Amyloid-β: the seeds of darkness.
Fodero-Tavoletti MT; Villemagne VL; Rowe CC; Masters CL; Barnham KJ; Cappai R
Int J Biochem Cell Biol; 2011 Sep; 43(9):1247-51. PubMed ID: 21601003
[TBL] [Abstract][Full Text] [Related]
29. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
30. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
31. Prion-like mechanisms in Alzheimer disease.
Walker LC
Handb Clin Neurol; 2018; 153():303-319. PubMed ID: 29887142
[TBL] [Abstract][Full Text] [Related]
32. Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
Eisele YS; Duyckaerts C
Acta Neuropathol; 2016 Jan; 131(1):5-25. PubMed ID: 26715565
[TBL] [Abstract][Full Text] [Related]
33. Emergence of distinct and heterogeneous strains of amyloid beta with advanced Alzheimer's disease pathology in Down syndrome.
Maxwell AM; Yuan P; Rivera BM; Schaaf W; Mladinov M; Prasher VP; Robinson AC; DeGrado WF; Condello C
Acta Neuropathol Commun; 2021 Dec; 9(1):201. PubMed ID: 34961556
[TBL] [Abstract][Full Text] [Related]
34. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
Xu L; Chen Y; Wang X
Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
[TBL] [Abstract][Full Text] [Related]
35. Potential therapeutic implications of gelsolin in Alzheimer's disease.
Ji L; Zhao X; Hua Z
J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622
[TBL] [Abstract][Full Text] [Related]
36. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
37. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ
PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279
[TBL] [Abstract][Full Text] [Related]
38. Engineering of a peptide probe for β-amyloid aggregates.
Aoraha E; Candreva J; Kim JR
Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
[TBL] [Abstract][Full Text] [Related]
39. Identifying Aβ-specific pathogenic mechanisms using a nematode model of Alzheimer's disease.
Hassan WM; Dostal V; Huemann BN; Yerg JE; Link CD
Neurobiol Aging; 2015 Feb; 36(2):857-66. PubMed ID: 25457027
[TBL] [Abstract][Full Text] [Related]
40. Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
Aleksis R; Oleskovs F; Jaudzems K; Pahnke J; Biverstål H
Biochimie; 2017 Sep; 140():176-192. PubMed ID: 28751216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
